Navigation Links
Miami’s Preferred Cord Blood Laboratory, GeneCell International, Partakes in North Shore Medical Center and Hialeah Hospital’s OB/GYN Symposium
Date:9/20/2013

Miami, Florida (PRWEB) September 20, 2013

The OB/GYN Symposium will be focused on the areas of cancer and genetic screening, management of cervical dysplasia, fetal neural protection, and other related topics in the field of OB/GYN. The symposium is set to take place on Saturday, September 21, 2013, from 7 a.m. to 7 p.m. at the Doral Golf Resort & Spa, located at 4400 N.W. 87th Avenue, Miami, FL 33178.

“We believe in offering the best support to the medical community, this will ensure doctors will provide parents with the best and most up-to-date information so they are able to make an informed decision on preserving their child’s stems cells,” said GeneCell’s Physician’s Relation’s Manager, Lisa Reyes Munoz.

GeneCell International specializes in the collection, transport, processing and cryogenic storage of adult stem cells from various sources including; umbilical cord blood, cord tissue segment (known as Wharton’s Jelly), dental pulp (teeth) and adipose tissue (fat) that can later be used to treat a variety of diseases. The laboratory is also involved in scientific research and development with a range of stem cells from various adult tissues. The facility is governed and inspected by the FDA, Florida Department of Health and several other regulating bodies to ensure the safety of these cellular therapies.

“For me, the opportunity for meeting and discussing the scientific aspect of these life-saving cells with the physicians is rewarding," added GeneCell’s Laboratory Manager, Priscilla Pages.

Cord blood is rich in stem cells and there are fewer risks for the recipient’s immune system to reject the cells, because certain immune cells found in the cord blood are not mature. Cord blood can be used to treat the child from whom the blood was collected as well as some first-degree relatives who are a close genetic match, such as family members. Additionally, patients can get the treatment in about three weeks - as opposed to six to eight for bone marrow from an adult donor.

“Informing all attending physicians on the importance of cord blood banking and the differences between these non-controversial cells is imperative,” added GeneCell’s Director of Operations, Jose Cirino

GeneCell International presently conducts monthly cord blood workshops at its Miami, West Kendall, facility in order to further educate and update the community on the advancements of stem cells, both hematopoietic (cord) and mesenchymal (cord tissue, dental and adipose).

Umbilical cord blood preservation is a process by which blood is collected from the umbilical cord of a newborn baby and is stored cryogenically in a specially-designated bank. According to the National Marrow Donor Program, cord blood contains cells that can be transfused to a patient to treat various diseases, including lymphoma and leukemia. Currently, there are approximately 80 diseases and the list of illnesses utilizing cord blood stem cells, as a treatment, continues to grow.

GeneCell International, LLC is a trusted provider in the collection, processing and storage of adult stem cells from various sources which have the potential to treat a variety of diseases and disorders. Headquartered in Miami, Florida and a local office in Central Florida and international offices or laboratories in Colombia, Costa Rica, Dominican Republic, Honduras, India, Peru, Puerto Rico, and Venezuela, GeneCell operates state of the art laboratories and storage facilities for the cord blood and dental pulp of thousands of clients. For more information and to learn more about cord blood banking, dental pulp or other GeneCell services, please visit our website at http://www.GeneCell.com.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11143568.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. GeneCell International, Miami’s Preferred Cord Blood Laboratory, is Pleased to Announce That July is National Cord Blood Awareness Month
2. CellerateRX® Added to List of Preferred Products for Golden Living Healthcare Network
3. BioMed Realty Trust Declares Fourth Quarter 2011 Common Stock and Preferred Stock Dividends
4. Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock
5. BioMed Realty Trust Declares Second Quarter 2012 Common Stock And Preferred Stock Dividends
6. Ekahau - A Preferred Provider of Real-Time Location Solutions - Is Awarded an Agreement with the Premier Healthcare Alliance
7. University of Colorado Cancer Center Study Shows the Preferred Feeding Method is not the Medically Best in Malnourished Pediatric Cancer Patients
8. Despite Lucentiss Recent Expanded Label for Diabetic Macular Edema, Avastin Remains the Preferred Intravitreal Therapy for Diabetic Macular Edema in the United States
9. FindTheBest Helps Parents Find Cord Blood Banks
10. Cord Blood America Announces DTCC Removes "Chill" Imposed in December 2010
11. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... IsoPlexis ... against cancer, autoimmune disease and more through a single-cell precision engineering platform, today ... analysis platform developed in the laboratory of Dr. James Heath at the ...
(Date:3/27/2017)... 2017  Perthera,s Chief Bioinformatics Officer and research faculty ... , Ph.D., will be speaking at the American Medical ... March 27, 2017, she will be speaking on the ... Research and Care" (from 10:30 a.m. – 12:00 p.m. ... be a participant in the "Making Precision Oncology Data ...
(Date:3/27/2017)... , March 27, 2017 DarioHealth Corp. ... mobile health and big data solutions, today announced that ... insurance coverage option for U.S. consumers who want to ... DarioHealth has signed strategic alliance agreements with partners ... insurance coverage benefits, and if approved, will supply and ...
(Date:3/24/2017)... March 24, 2017 Sinovac Biotech Ltd. ("Sinovac" or the ... China , today announced that its board of directors ... of the plan from March 27, 2017 to March 27, 2018. The ... About Sinovac Biotech Ltd. ... Sinovac Biotech Ltd. is a ...
Breaking Biology Technology:
(Date:3/1/2017)... Mass. , March 1, 2017  Aware, Inc. ... services, announced that Richard P. Moberg has ... and co-President and Chief Financial Officer and Treasurer of ... continue to serve as a member of the Board ... Russell , Aware,s co-Chief Executive Officer and co-President, General ...
(Date:2/27/2017)... 2017   Strategic Cyber Ventures , the industry,s ... a $3.5 million investment in  Polarity , the first ... is DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran ... this series A round of funding. This new funding ...
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. ... the Avamere Family of Companies (Avamere Health Services, Infinity ... a six-month research study that will apply the power ... at senior living and health centers. By analyzing data ... to gain insights into physical and environmental conditions, and ...
Breaking Biology News(10 mins):